Press Releases

EIN Presswire

Green Globe confirms its certification programme aligns with requirements of European Union’s Empowering Consumers for the Green Transition Directive (EmpCo) LUXEMBOURG CITY, LUXEMBOURG, May 13, 2026 /⁨EINPresswire.com⁩/ -- Green Globe...

GlobeNewswire, Inc.

ROCKVILLE, Md. and SUZHOU, China, May 12, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, integrated biopharmaceutical company engaged in the discovery, development and commercialization of...

GlobeNewswire, Inc.

- Duchenne (SGT-003): First participant dosed in the Phase 3 IMPACT DUCHENNE clinical trial, receipt of positive opinion on the Company’s Pediatric Investigation Plan from the European Medicines Agency and Orphan drug designation from the European...

GlobeNewswire, Inc.

Orchestra BioMed targeting enrollment completion of BACKBEAT Global Pivotal Trial (“BACKBEAT Trial”) by the end of Q3 2026 Medtronic (NYSE: MDT) and Orchestra BioMed intend to pursue late-breaking clinical trial presentation at major cardiology...

GlobeNewswire, Inc.

Completed spin-off of First Tracks Biotherapeutics, Inc., its former biopharma operations business Now exclusively manages the financial collaborations for Jemperli with GSK and imsidolimab with Vanda Announced appointment of Chris Murphy as CFO...

GlobeNewswire, Inc.

Proprietary robotically-navigated MAGiC catheter received U.S. FDA approval in January and is now being utilized at multiple sites across the United States as well as Europe Synchrony digital operating room system received U.S. FDA clearance in...

GlobeNewswire, Inc.

Topline data from CHAPTER-3, a pivotal Phase 3 study of deucrictibant XR for the prophylaxis of HAE attacks, expected in 3Q2026 Timeline for submission of NDA of deucrictibant IR for the on-demand treatment of HAE attacks remains on-track in...

GlobeNewswire, Inc.

Next anticipated Revita® clinical data readouts are 1-year data from the REVEAL-1 Cohort in Q2 2026 and 1-year randomized data from the REMAIN-1 Midpoint Cohort in Q3 2026 Early Q4 2026 timing for topline 6-month randomized data from the REMAIN-1...

GlobeNewswire, Inc.

C-BEYOND Phase 3 North American Trial for Treatment of Hepatitis C Virus (HCV) Remains on Track with Topline Results Expected Mid-2026 C-FORWARD Phase 3 Trial Outside North America for Treatment of HCV on Track to Complete Enrollment Mid-2026;...

GlobeNewswire, Inc.

BRISBANE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today...

EIN Presswire

Business teams gain access to AI experts they need at a fraction of the cost of full-time resources SEATTLE, WA, UNITED STATES, May 12, 2026 /⁨EINPresswire.com⁩/ -- rGen Consulting, a business consulting firm specializing in AI workforce...

EIN Presswire

HELSINKI, FINLAND, May 12, 2026 /⁨EINPresswire.com⁩/ -- The European Union-backed SUPREME project has officially kicked off in Helsinki, marking the start of a €50 million ($56 million) initiative to industrialize superconducting quantum...

GlobeNewswire, Inc.

ISTANBUL, May 12, 2026 (GLOBE NEWSWIRE) -- FL PR and Communications, the London and Istanbul based international public relations and strategic communications agency, attended the Türkiye-Belgium Business Forum held at Swissotel in Istanbul on 11...

EIN Presswire

WARSAW, POLAND, May 12, 2026 /⁨EINPresswire.com⁩/ -- Polish project management and construction planning company ADC Sp. z o.o. has become part of the global consulting company Drees & Sommer, which has acquired 100 percent of the shares in ADC....

GlobeNewswire, Inc.

BERKELEY, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced two abstracts have been accepted for oral presentations at the...

GlobeNewswire, Inc.

– Company unveils first proof-of concept clinical data of AJ1-11095 in patients with myelofibrosis who have been previously treated with a type I JAK2 Inhibitor – NEW YORK and CAMBRIDGE, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Ajax Therapeutics,...

GlobeNewswire, Inc.

Oral presentation of data from RALLY-MF phase 2 trial of DISC-0974 in patients with myelofibrosis and anemia Additional abstracts highlighting updates on HELIOS open label extension study of bitopertin in EPP, EPP LIGHT study (patient survey on...

GlobeNewswire, Inc.

Pivotal data from APEX trial in Advanced Systemic Mastocytosis accepted for oral presentation; Cogent’s third oral presentation of pivotal data with bezuclastinib at major medical meetings Preclinical data from selective, potent JAK2 V617F program...

GlobeNewswire, Inc.

LONDON, May 12, 2026 (GLOBE NEWSWIRE) -- TMF Group, a leading provider of compliance and administrative services, today launches the 13th edition of the Global Business Complexity Index (GBCI), which shows that operating across borders is becoming...

GlobeNewswire, Inc.

– Phase 2 Seabreeze STAT studies for acute exacerbations in asthma and COPD continuing as planned based on independent DMC review of pre-specified interim analysis – – Expect to report topline data from both Phase 2 Seabreeze STAT studies mid-2026...